Clinical Trials Browser

Neoplasm, Residual × Gastrointestinal × Clear all

NCT07524114 2026-04-13

SHERLOCK

BreastDermatologicGastrointestinalHead & NeckThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Unknown Primary, Urogenital Neoplasms, Neoplasm, Residual

NCT07136077 2026-04-06

A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT07454486 2026-03-06

TRACE-BTC

Not yet recruiting

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma, Klatskin Tumor, Neoplasm, Residual

NCT07413146 2026-02-17

Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

Phase NA Not yet recruiting

Gastrointestinal

Colonic Neoplasms, Neoplasm, Residual

NCT06358430 2026-01-15

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

Phase 1 Recruiting

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT04853017 2025-09-05

AMPLIFY-201

Phase 1 Completed

25 enrolled 15 charts

GastrointestinalGynecologicThoracic

Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Neoplasm, Residual

NCT06287814 2025-07-10

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

NCT05196087 2025-07-02

NIP IT!

BreastDermatologicEndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Breast Neoplasms, Melanoma, Neoplasm, Residual

NCT06111105 2025-03-30

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing CtDNA Diagnostics - Colorectal Cancer

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05534087 2024-11-29

CLAUDIA

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms, Neoplasm, Residual

NCT05965479 2024-11-12

DECIPHER

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms, Neoplasm, Residual

NCT06498752 2024-08-06

MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Neoplasm, Residual

NCT06253650 2024-06-13

TRINITY

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms, Neoplasm, Residual

NCT06449846 2024-06-10

Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular Carcinoma

Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Neoplasm, Residual

NCT06404593 2024-05-08

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05219734 2024-03-12

MARIA

Active not recruiting

GastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

NCT06287723 2024-03-01

French Assessment of MRD by Liquid Biopsies in Colorectal With Liver Metastasis Patients (FRENCH.MRD.CRLM)

Not yet recruiting

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05371873 2023-09-13

A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer

Gastrointestinal

Chromosome Aberrations, Carcinoma, Hepatocellular, Neoplasm, Residual

NCT05969938 2023-08-01

Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology

Gastrointestinal

Rectal Neoplasms, Neoplasm, Residual

NCT05952661 2023-07-19

ECMRD-001

Gastrointestinal

Esophageal Neoplasms, Neoplasm, Residual

NCT05900583 2023-06-12

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm, Residual

NCT05867901 2023-05-31

Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence

GastrointestinalSarcoma

Neoplasm, Residual, Gastrointestinal Stromal Tumors

NCT03189576 2023-05-26

Measuring Molecular Residual Disease in Colorectal Cancer After Primary Surgery and Resection of Metastases

Phase NA Unknown

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05743959 2023-05-22

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers：A Multicenter Prospective Trial

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma, Neoplasm, Residual

NCT05427669 2022-10-07

AFFORD

Phase 3 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms, Neoplasm, Residual

NCT05408897 2022-09-21

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

GastrointestinalSarcoma

Neoplasm, Residual, Gastrointestinal Stromal Tumors

NCT02314871 2019-03-13

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

Phase 4 Completed

Gastrointestinal

Colonic Neoplasms, Neoplasms, Neoplasm, Residual

NCT02900950 2016-09-15

MPM

Phase NA Completed

Gastrointestinal

Margins of Excision, Neoplasms, Pancreatic Neoplasms, Neoplasm, Residual